» Articles » PMID: 18829286

The Gastrointestinal Microbiota Affects the Selenium Status and Selenoprotein Expression in Mice

Overview
Journal J Nutr Biochem
Date 2008 Oct 3
PMID 18829286
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the selenium-dependent glutathione peroxidases, GPx2. Since bacterial colonization of the gastrointestinal tract is associated with stress, we aimed to clarify how bacteria affect selenoprotein expression in unstressed conditions. GF and conventional (CV) FVB/NHan(TMHsd) mice were fed a selenium-poor (0.086 ppm) or a selenium-adequate (0.15 ppm) diet for 5 weeks starting from weaning. Each group consisted of five animals. Specific glutathione peroxidase (GPx) and thioredoxin reductase (TrxR) expression was measured in plasma, liver and intestinal sections by activity, protein and mRNA level as appropriate. Under selenium-adequate conditions, selenoprotein expression did not differ in GF and CV mice. Under selenium-limiting conditions, however, GF mice generally contained higher GPx and TrxR activities in the intestine and liver, higher GPx1 protein and RNA levels in the liver, higher GPx2 protein levels in the proximal and distal jejunum and colon and higher GPx1 and GPx2 RNA levels in the colon. In addition, higher selenium concentrations were estimated in plasma, liver and cecum. All differences were significant. It is concluded that bacteria may compete with the host for selenium when availability becomes limiting. A variable association with different microorganisms might influence the daily requirement of mice for selenium. Whether the microbiota also affects the human selenoprotein status appears worthy of investigation.

Citing Articles

Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy.

Bhatnagar K, Jha K, Dalal N, Patki N, Gupta G, Kumar A Front Immunol. 2024; 15:1442788.

PMID: 39676876 PMC: 11638209. DOI: 10.3389/fimmu.2024.1442788.


Selenium, Immunity, and Inflammatory Bowel Disease.

Sousa J, McKay D, Raman M Nutrients. 2024; 16(21).

PMID: 39519453 PMC: 11547411. DOI: 10.3390/nu16213620.


Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches.

Clemente-Suarez V, Redondo-Florez L, Rubio-Zarapuz A, Martin-Rodriguez A, Tornero-Aguilera J Biomedicines. 2024; 12(1).

PMID: 38255326 PMC: 10813640. DOI: 10.3390/biomedicines12010221.


The relationship between thyroid and human-associated microbiota: A systematic review of reviews.

Virili C, Stramazzo I, Bagaglini M, Carretti A, Capriello S, Romanelli F Rev Endocr Metab Disord. 2023; 25(1):215-237.

PMID: 37824030 PMC: 10808578. DOI: 10.1007/s11154-023-09839-9.


Micronutrient Status and Prediction of Disease Outcome in Adults With Inflammatory Bowel Disease Receiving Biologic Therapy.

Brownson E, Saunders J, Jatkowska A, White B, Gerasimidis K, Seenan J Inflamm Bowel Dis. 2023; 30(8):1233-1240.

PMID: 37611079 PMC: 11291620. DOI: 10.1093/ibd/izad174.